|
1
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar
|
|
2
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: Cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar
|
|
3
|
Levings PP, McGarry SV, Currie TP,
Nickerson DM, McClellan S, Ghivizzani SC, Steindler DA and Gibbs
CP: Expression of an exogenous human Oct-4 promoter identifies
tumor-initiating cells in osteosarcoma. Cancer Res. 69:5648–5655.
2009. View Article : Google Scholar :
|
|
4
|
Hattinger CM, Fanelli M, Tavanti E, Vella
S, Ferrari S, Picci P and Serra M: Advances in emerging drugs for
osteosarcoma. Expert Opin Emerg Drugs. 20:495–514. 2015. View Article : Google Scholar
|
|
5
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar :
|
|
6
|
Ernst C and Morton CC: Identification and
function of long non-coding RNA. Front Cell Neurosci. 7:1682013.
View Article : Google Scholar :
|
|
7
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar
|
|
8
|
Maass PG, Luft FC and Bähring S: Long
non-coding RNA in health and disease. J Mol Med (Berl). 92:337–346.
2014. View Article : Google Scholar
|
|
9
|
Carpenter S, Aiello D, Atianand MK, Ricci
EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB,
et al: A long noncoding RNA mediates both activation and repression
of immune response genes. Science. 341:789–792. 2013. View Article : Google Scholar :
|
|
10
|
Zhou Q, Chen F, Fei Z, Zhao J, Liang Y,
Pan W, Liu X and Zheng D: Genetic variants of lncRNA HOTAIR
contribute to the risk of osteosarcoma. Oncotarget. 7:19928–19934.
2016. View Article : Google Scholar :
|
|
11
|
Yin Z, Ding H, He E, Chen J and Li M:
Overexpression of long non-coding RNA MFI2 promotes cell
proliferation and suppresses apoptosis in human osteosarcoma. Oncol
Rep. 36:2033–2040. 2016. View Article : Google Scholar
|
|
12
|
Luo W, He H, Xiao W, Liu Q, Deng Z, Lu Y,
Wang Q, Zheng Q and Li Y: MALAT1 promotes osteosarcoma development
by targeting TGFA via MIR376A. Oncotarget. 7:54733–54743. 2016.
View Article : Google Scholar :
|
|
13
|
Uzan VR, Lengert A, Boldrini É, Penna V,
Scapulatempo-Neto C, Scrideli CA, Filho AP, Cavalcante CE, de
Oliveira CZ, Lopes LF and Vidal DO: High expression of HULC is
associated with poor prognosis in osteosarcoma patients. PLoS One.
11:e01567742016. View Article : Google Scholar :
|
|
14
|
Li F, Cao L, Hang D, Wang F and Wang Q:
Long non-coding RNA HOTTIP is up-regulated and associated with poor
prognosis in patients with osteosarcoma. Int J Clin Exp Pathol.
8:11414–11420. 2015.
|
|
15
|
Cong M, Li J, Jing R and Li Z: Long
non-coding RNA tumor suppressor candidate 7 functions as a tumor
suppressor and inhibits proliferation in osteosarcoma. Tumour Biol.
37:9441–9450. 2016. View Article : Google Scholar
|
|
16
|
Wang Y, Zhang L, Zheng X, Zhong W, Tian X,
Yin B, Tian K and Zhang W: Long non-coding RNA LINC00161 sensitises
osteosarcoma cells to cisplatin-induced apoptosis by regulating the
miR-645-IFIT2 axis. Cancer Lett. 382:137–146. 2016. View Article : Google Scholar
|
|
17
|
Cao Y, Xu R, Xu X, Zhou Y, Cui L and He X:
Downregulation of lncRNA CASC2 by microRNA-21 increases the
proliferation and migration of renal cell carcinoma cells. Mol Med
Rep. 14:1019–1025. 2016. View Article : Google Scholar
|
|
18
|
Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J
and Xue YX: Long non-coding RNA CASC2 suppresses malignancy in
human gliomas by miR-21. Cell Signal. 27:275–282. 2015. View Article : Google Scholar
|
|
19
|
Huang G, Wu X, Li S, Xu X, Zhu H and Chen
X: The long noncoding RNA CASC2 functions as a competing endogenous
RNA by sponging miR-18a in colorectal cancer. Sci Rep. 6:265242016.
View Article : Google Scholar :
|
|
20
|
He X, Liu Z, Su J, Yang J, Yin D, Han L,
De W and Guo R: Low expression of long noncoding RNA CASC2
indicates a poor prognosis and regulates cell proliferation in
non-small cell lung cancer. Tumour Biol. 37:9503–9510. 2016.
View Article : Google Scholar
|
|
21
|
Baldinu P, Cossu A, Manca A, Satta MP,
Sini MC, Rozzo C, Dessole S, Cherchi P, Gianfrancesco F, Pintus A,
et al: Identification of a novel candidate gene, CASC2, in a region
of common allelic loss at chromosome 10q26 in human endometrial
cancer. Hum Mutat. 23:318–326. 2004. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Godbole GB, Modi DN and Puri CP:
Regulation of homeobox A10 expression in the primate endometrium by
progesterone and embryonic stimuli. Reproduction. 134:513–523.
2007. View Article : Google Scholar
|
|
24
|
Cheon KW, Lee HS, Parhar IS and Kang IS:
Expression of the second isoform of gonadotrophin-releasing hormone
(GnRH-II) in human endometrium throughout the menstrual cycle. Mol
Hum Reprod. 7:447–452. 2001. View Article : Google Scholar
|
|
25
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar :
|
|
26
|
Fan H, Liu G, Zhao C, Li X and Yang X:
Transcription factor Oct4 promotes osteosarcoma by regulating
lncRNA AK055347. Oncol Lett. 13:396–402. 2017.
|
|
27
|
Li Z, Shen J, Chan MT and Wu WK: TUG1: A
pivotal oncogenic long non-coding RNA of human cancers. Cell
Prolif. 49:471–475. 2016. View Article : Google Scholar
|
|
28
|
Ye K, Wang S, Zhang H, Han H, Ma B and Nan
W: Long noncoding RNA GAS5 suppresses cell growth and
epithelial-mesenchymal transition in osteosarcoma by regulating the
miR-221/ARHI pathway. J Cell Biochem. May 18–2017.(Epub ahead of
print). View Article : Google Scholar
|
